Clinical Therapeutics/New Technology-Insulin Delivery Systems

Clinical Therapeutics/New Technology-Insulin Delivery Systems

You have access
Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial
Leah M. Wilson, Peter G. Jacobs, Katrina L. Ramsey, Navid Resalat, Ravi Reddy, Deborah Branigan, Joseph Leitschuh, Virginia Gabo, Florian Guillot, Brian Senf, Joseph El Youssef, Isabelle Isa Kristin Steineck, Nichole S. Tyler, Jessica R. Castle

Diabetes Care Nov 2020, 43 (11) 2721-2729; DOI: 10.2337/dc19-2267
You have access
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
Sybil A. McAuley, Melissa H. Lee, Barbora Paldus, Sara Vogrin, Martin I. de Bock, Mary B. Abraham, Leon A. Bach, Morton G. Burt, Neale D. Cohen, Peter G. Colman, Elizabeth A. Davis, Christel Hendrieckx, D. Jane Holmes-Walker, Joey Kaye, Anthony C. Keech, Kavita Kumareswaran, Richard J. MacIsaac, Roland W. McCallum, Catriona M. Sims, Jane Speight, Stephen N. Stranks, Vijaya Sundararajan, Steven Trawley, Glenn M. Ward, Alicia J. Jenkins, Timothy W. Jones, David N. O’Neal

Diabetes Care Dec 2020, 43 (12) 3024-3033; DOI: 10.2337/dc20-1447
You have access
Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis
Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas

Diabetes Care Aug 2020, 43 (8) 1967-1975; DOI: 10.2337/dc19-1785
Open Access
Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38–e39
Pierre Yves Benhamou, Stéphanie Madrolle, Sandrine Lablanche, Alexandre Gallegos, Yousra Tourki, Sylvia Franc, Maeva Doron, Guillaume Charpentier

Diabetes Care Oct 2020, 43 (10) e167; DOI: 10.2337/dc20-1291
Open Access
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial
Martin Tauschmann, Janet M. Allen, Katrin Nagl, Maria Fritsch, James Yong, Emily Metcalfe, Dominique Schaeffer, Muriel Fichelle, Ulrike Schierloh, Alena G. Thiele, Daniela Abt, Harald Kojzar, Julia K. Mader, Sonja Slegtenhorst, Nicole Barber, Malgorzata E. Wilinska, Charlotte Boughton, Gianluca Musolino, Judy Sibayan, Nathan Cohen, Craig Kollman, Sabine E. Hofer, Elke Fröhlich-Reiterer, Thomas M. Kapellen, Carlo L. Acerini, Carine de Beaufort, Fiona Campbell, Birgit Rami-Merhar, Roman Hovorka

Diabetes Care Apr 2019, 42 (4) 594-600; DOI: 10.2337/dc18-1881
Open Access
Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes
Lalantha Leelarathna, Hood Thabit, Malgorzata E. Willinska, Lia Bally, Julia K. Mader, Sabine Arnolds, Carsten Benesch, Thomas R. Pieber, Viral N. Shah, Anders L. Carlson, Richard M. Bergenstal, Mark L. Evans, Roman Hovorka

Diabetes Care Mar 2020, 43 (3) e38-e39; DOI: 10.2337/dc19-2041
Open Access
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
Ahmad Haidar, Michael A. Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault

Diabetes Care Mar 2020, 43 (3) 597-606; DOI: 10.2337/dc19-1922
You have access
Randomized Controlled Trial of Mobile Closed-Loop Control
Boris Kovatchev, Stacey M. Anderson, Dan Raghinaru, Yogish C. Kudva, Lori M. Laffel, Carol Levy, Jordan E. Pinsker, R. Paul Wadwa, Bruce Buckingham, Francis J. Doyle, Sue A. Brown, Mei Mei Church, Vikash Dadlani, Eyal Dassau, Laya Ekhlaspour, Gregory P. Forlenza, Elvira Isganaitis, David W. Lam, John Lum, Roy W. Beck

Diabetes Care Mar 2020, 43 (3) 607-615; DOI: 10.2337/dc19-1310
Open Access
Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589
Juan Jose Delgado-Hurtado, Alicia Armstrong, Sushela Chaidarun

Diabetes Care Jan 2019, 42 (1) e14; DOI: 10.2337/dc18-1929
You have access
Lung Cancer–Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results
Nicolle M. Gatto, Daniel O. Koralek, Michael B. Bracken, William T. Duggan, Joanna Lem, Sol Klioze, Gary G. Koch, Robert A. Wise, Roger B. Cohen, Neville C. Jackson

Diabetes Care Sep 2019, 42 (9) 1708-1715; DOI: 10.2337/dc18-2529

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Insulin Delivery Systems

Pages

Navigation

Information

ADA Journals

Other ADA Resources